Churchill Management’s AbbVie ABBV Stock Holding History

Churchill Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-81,731	Closed	-$13M	–	140
2023 Q1	$13M	Buy	81,731 +2,177	+3%	+$333K	0.27%	39
2022 Q4	$12.9M	Buy	79,554 +1,604	+2%	+$246K	0.31%	40
2022 Q3	$10.5M	Buy	77,950 +28,530	+58%	+$4.09M	0.28%	48
2022 Q2	$7.57M	Buy	49,420 +6,385	+15%	+$976K	0.19%	68
2022 Q1	$6.98M	Buy	43,035 +3,516	+9%	+$511K	0.12%	88
2021 Q4	$5.35M	Sell	39,519 -693	-2%	-$81.9K	0.07%	123
2021 Q3	$4.34M	Sell	40,212 -200	-0.5%	-$22.9K	0.07%	124
2021 Q2	$4.55M	Sell	40,412 -1,377	-3%	-$155K	0.07%	125
2021 Q1	$4.52M	Sell	41,789 -128,098	-75%	-$13.7M	0.07%	120
2020 Q4	$18.2M	Sell	169,887 -6,879	-4%	-$661K	0.31%	41
2020 Q3	$15.5M	Sell	176,766 -1,317	-0.7%	-$124K	0.38%	30
2020 Q2	$17.5M	Buy	178,083 +2,582	+1%	+$227K	0.54%	22
2020 Q1	$13.4M	Buy	175,501 +31,244	+22%	+$2.66M	0.67%	25
2019 Q4	$12.8M	Buy	+144,257	New	+$12M	0.24%	57
2018 Q4	–	Sell	-126,531	Closed	-$12M	–	104
2018 Q3	$12M	Buy	+126,531	New	+$12M	0.26%	48
2018 Q2	–	Sell	-248,704	Closed	-$23.5M	–	115
2018 Q1	$23.5M	Sell	248,704 -13,833	-5%	-$1.52M	0.68%	20
2017 Q4	$25.4M	Sell	262,537 -6,759	-3%	-$637K	0.56%	22
2017 Q3	$23.9M	Sell	269,296 -15,512	-5%	-$1.18M	0.59%	21
2017 Q2	$20.7M	Sell	284,808 -5,674	-2%	-$381K	0.54%	31
2017 Q1	$18.9M	Buy	290,482 +15,273	+6%	+$960K	0.54%	39
2016 Q4	$17.2M	Buy	275,209 +13,184	+5%	+$805K	0.57%	36
2016 Q3	$16.5M	Buy	262,025 +27,629	+12%	+$1.79M	0.68%	33
2016 Q2	$14.5M	Buy	234,396 +27,971	+14%	+$1.7M	0.95%	30
2016 Q1	$11.8M	Buy	+206,425	New	+$11.5M	0.83%	30

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Churchill Management's ABBV Position: Q2 2023 in Review

Churchill Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 81,731 shares — an estimated $13M sold.

Churchill Management first reported a position in ABBV in Q1 2016 and held it in 24 quarters. The position peaked at $25.4M in Q4 2017. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Churchill Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Churchill Management sold 81,731 AbbVie shares in Q2 2023, an estimated $13M.
Churchill Management first reported a position in AbbVie in Q1 2016 and held it in 24 quarters.
Churchill Management's AbbVie position peaked at $25.4M in Q4 2017.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Churchill Management's 13F filing for Q2 2023, filed 18 Jul 2023.